
Cooper Companies (COO) Stock Forecast & Price Target
Cooper Companies (COO) Analyst Ratings
Bulls say
CooperCompanies has demonstrated strong financial growth with an operating margin of 27.0%, which is an increase of 120 basis points year-over-year and surpasses consensus expectations. The company is projecting free cash flow for FY26 to reach between $575 million and $625 million, representing a significant year-over-year increase of 33% to 44%. Additionally, CooperSurgical's Paragard product experienced a 16% year-over-year growth in revenue, indicating robust demand and aligning with management's positive outlook for future performance despite potential competitive pressures.
Bears say
CooperCompanies is experiencing a downward trend in its financial outlook, with annual revenue growth estimates being revised down from +5.3% to +4.9%, largely due to ongoing competitive pressures from e-commerce vendors in the Asia-Pacific region. The company's gross margin has declined to 66.2%, slightly below consensus expectations, attributed to increased tariffs and an unfavorable product mix, reflecting adverse impacts on profitability. Additionally, the reliance on Paragard, which is facing challenges with a forecasted EPS decline contributing to overall earnings headwinds, raises concerns about sustained growth and operational margins.
This aggregate rating is based on analysts' research of Cooper Companies and is not a guaranteed prediction by Public.com or investment advice.
Cooper Companies (COO) Analyst Forecast & Price Prediction
Start investing in Cooper Companies (COO)
Order type
Buy in
Order amount
Est. shares
0 shares